Linaclotide News

Biomarkers and Translational Medicine in Early Phase Oncology Clinical Development (Part two of our three part series)
Increasingly, new technologies are making it possible to carefully identify sets of patien
Active Directory & the Cloud for Biotech & Pharma
Biotech and pharmaceutical companies are leaders cloud/SaaS technology adoption. This webi
Webinar: Next Gen Sequencing from FFPE Samples
Next generation sequencing (NGS) technologies hold enormous promise to advance personalize
Drug Development: An Overview of the Regulated Clinical Trials Process Used to Bring a New Drug to Market
Join us for a one-hour overview of the regulated clinical trials process used to bring a n

September 14, 2010 — 7:10am ET | By Maureen Martino

2009 Fierce 15 company Ironwood Pharmaceuticals has revealed positive top-line results from a Phase III clinical trial of a once-daily dosing of linaclotide in 803 patients with irritable bowel Read more...

Free Newsletter